Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic.

Martín R, Miquel S, Benevides L, Bridonneau C, Robert V, Hudault S, Chain F, Berteau O, Azevedo V, Chatel JM, Sokol H, Bermúdez-Humarán LG, Thomas M, Langella P.

Front Microbiol. 2017 Jun 30;8:1226. doi: 10.3389/fmicb.2017.01226. eCollection 2017.

2.

Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.

Miquel S, Leclerc M, Martin R, Chain F, Lenoir M, Raguideau S, Hudault S, Bridonneau C, Northen T, Bowen B, Bermúdez-Humarán LG, Sokol H, Thomas M, Langella P.

MBio. 2015 Apr 21;6(2). pii: e00300-15. doi: 10.1128/mBio.00300-15.

3.

Apple peels, from seven cultivars, have lipase-inhibitory activity and contain numerous ursenoic acids as identified by LC-ESI-QTOF-HRMS.

McGhie TK, Hudault S, Lunken RC, Christeller JT.

J Agric Food Chem. 2012 Jan 11;60(1):482-91. doi: 10.1021/jf203970j. Epub 2011 Dec 23.

PMID:
22148752
4.

Human decay-accelerating factor and CEACAM receptor-mediated internalization and intracellular lifestyle of Afa/Dr diffusely adhering Escherichia coli in epithelial cells.

Guignot J, Hudault S, Kansau I, Chau I, Servin AL.

Infect Immun. 2009 Jan;77(1):517-31. doi: 10.1128/IAI.00695-08. Epub 2008 Nov 17.

5.

NOD2: a potential target for regulating liver injury.

Body-Malapel M, Dharancy S, Berrebi D, Louvet A, Hugot JP, Philpott DJ, Giovannini M, Chareyre F, Pages G, Gantier E, Girardin SE, Garcia I, Hudault S, Conti F, Sansonetti PJ, Chamaillard M, Desreumaux P, Dubuquoy L, Mathurin P.

Lab Invest. 2008 Mar;88(3):318-27. doi: 10.1038/labinvest.3700716. Epub 2008 Jan 28.

8.

Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity.

Liévin V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser JR, Servin AL.

Gut. 2000 Nov;47(5):646-52.

9.

The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo.

Bernet-Camard MF, Liévin V, Brassart D, Neeser JR, Servin AL, Hudault S.

Appl Environ Microbiol. 1997 Jul;63(7):2747-53.

10.

Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB.

Coconnier MH, Liévin V, Bernet-Camard MF, Hudault S, Servin AL.

Antimicrob Agents Chemother. 1997 May;41(5):1046-52.

11.

Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection.

Hudault S, Liévin V, Bernet-Camard MF, Servin AL.

Appl Environ Microbiol. 1997 Feb;63(2):513-8.

12.

Differentiation-associated antimicrobial functions in human colon adenocarcinoma cell lines.

Bernet-Camard MF, Coconnier MH, Hudault S, Servin AL.

Exp Cell Res. 1996 Jul 10;226(1):80-9.

PMID:
8660942
15.
17.

Elimination of Salmonella typhimurium from the digestive tract by the flora of conventional chicken.

Hudault S, Bewa H, Bridonneau C, Raibaud P.

Prog Clin Biol Res. 1985;181:163-7. No abstract available.

PMID:
3895233
18.

[Pathogenicity of various toxinogenic types of Clostridium perfringens administered by mouth to axenic and holoxenic mice].

Hudault S, Bridonneau C, Raibaud P.

Ann Microbiol (Paris). 1983 Sep-Oct;134B(2):277-83. French.

PMID:
6316828
19.
20.

Implantation of bacteria from the digestive tract of man and various animals into gnotobiotic mice.

Raibaud P, Ducluzeau R, Dubos F, Hudault S, Bewa H, Muller MC.

Am J Clin Nutr. 1980 Nov;33(11 Suppl):2440-7. doi: 10.1093/ajcn/33.11.2440.

PMID:
7001883
21.

[Factors influencing the growth and survival in Vittel mineral water of various bacteria of intestinal origin and of a strain of Pseudomonas fluorescens].

Ducluzeau R, Hudault S, Nicolas JL.

Nuovi Ann Ig Microbiol. 1979 May-Aug;30(3-4):243-5. French. No abstract available.

PMID:
121453

Supplemental Content

Loading ...
Support Center